[go: up one dir, main page]

DK0831881T3 - CETP til forøgelse af HDL-cholesterolniveau - Google Patents

CETP til forøgelse af HDL-cholesterolniveau

Info

Publication number
DK0831881T3
DK0831881T3 DK96918201T DK96918201T DK0831881T3 DK 0831881 T3 DK0831881 T3 DK 0831881T3 DK 96918201 T DK96918201 T DK 96918201T DK 96918201 T DK96918201 T DK 96918201T DK 0831881 T3 DK0831881 T3 DK 0831881T3
Authority
DK
Denmark
Prior art keywords
cetp
hdl cholesterol
cholesterol levels
increase hdl
stimulating
Prior art date
Application number
DK96918201T
Other languages
Danish (da)
English (en)
Inventor
Dennis J Carlo
Deborah Y Kwoh
Steven W Brostoff
Original Assignee
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avant Immunotherapeutics Inc filed Critical Avant Immunotherapeutics Inc
Application granted granted Critical
Publication of DK0831881T3 publication Critical patent/DK0831881T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Color Television Image Signal Generators (AREA)
  • Materials For Photolithography (AREA)
DK96918201T 1995-06-06 1996-06-05 CETP til forøgelse af HDL-cholesterolniveau DK0831881T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48245495A 1995-06-06 1995-06-06
PCT/US1996/009143 WO1996039168A1 (en) 1995-06-06 1996-06-05 Method for increasing hdl cholesterol level

Publications (1)

Publication Number Publication Date
DK0831881T3 true DK0831881T3 (da) 2003-07-07

Family

ID=23916145

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918201T DK0831881T3 (da) 1995-06-06 1996-06-05 CETP til forøgelse af HDL-cholesterolniveau

Country Status (9)

Country Link
US (1) US7074407B1 (de)
EP (1) EP0831881B1 (de)
JP (1) JP3910635B2 (de)
AT (1) ATE234109T1 (de)
CA (1) CA2223177A1 (de)
DE (1) DE69626642T2 (de)
DK (1) DK0831881T3 (de)
ES (1) ES2190470T3 (de)
WO (1) WO1996039168A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
ATE234109T1 (de) 1995-06-06 2003-03-15 Avant Immunotherapeutics Inc Cetp zur erhöhung des hdl-cholesterol-gehalts
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US6846808B1 (en) 1996-05-01 2005-01-25 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
JP2001520204A (ja) * 1997-10-20 2001-10-30 アヴァント イムノセラピューティクス，インコーポレーテッド コレステリルエステル運搬タンパク質（ｃｅｔｐ）活性を調節するための異種ｃｅｔｐ
US6300308B1 (en) * 1997-12-31 2001-10-09 Board Of Regents, The University Of Texas System Methods and compositions for inducing autoimmunity in the treatment of cancers
DE60036132T2 (de) * 1999-12-13 2008-08-21 Universidad Nacional Autonoma De Mexico Quantitative immunoenzymatische messmethode
MX347400B (es) * 2012-06-29 2017-04-18 Univ Nac Autónoma De México Vacuna de aplicacion nasal contra el desarrollo de la enfermedad aterosclerotica y el higado graso.
TW201627318A (zh) 2014-10-22 2016-08-01 臺北醫學大學 膽固醇酯轉運蛋白抗原肽及其融合蛋白以及其組合物及應用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143305A (en) 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US5126399A (en) 1986-04-30 1992-06-30 Board Of Regents, The University Of Texas System Methods and compositions for the preparation and use of site-directed immunologic reagents
US5338829A (en) 1988-04-20 1994-08-16 Trustees Of The University Of Pennsylvania Peptides derived from human immunodeficiency virus-1 GP160
GB8812214D0 (en) 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
US5242687A (en) 1989-03-15 1993-09-07 Tkb Associates Limited Partnership Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells
US5264341A (en) * 1989-08-30 1993-11-23 Eli Lilly And Company Selective cloning for high monoclonal antibody secreting hybridomas
CA2098101A1 (en) 1990-12-10 1992-06-10 Carl R. Alving A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
WO1993011782A1 (en) * 1991-12-19 1993-06-24 Southwest Foundation For Biomedical Research Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
WO1993023076A1 (en) 1992-05-20 1993-11-25 The Johns-Hopkins University Alternative receptor therapy
US5279540A (en) 1992-09-24 1994-01-18 Davidson Michael H Method for reducing the risk of atherosclerosis
US5618683A (en) 1993-04-13 1997-04-08 Brocia; Robert W. Diagnostic kit for cholesteryl ester transfer protein (CETP) activity measurement and a new synthetic particle used therein
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
DE69431114T2 (de) 1993-04-27 2003-03-13 United Biomedical, Inc. Immunogene lhrh peptidkonstrukion und synthetische, universale immunstimulatoren als impfstoffe
AU683295B2 (en) * 1993-08-04 1997-11-06 Texas Biomedical Research Institute CETP inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
DK96493D0 (da) 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
JPH09501186A (ja) 1994-11-12 1997-02-04 株式会社エルジ化学 コレステリルエステル運搬蛋白質阻害ペプチドおよびこれを含む動脈硬化症のための予防および治療剤
US5705388A (en) 1994-12-23 1998-01-06 Ribozyme Pharmaceuticals, Inc. CETP Ribozymes
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
ATE234109T1 (de) 1995-06-06 2003-03-15 Avant Immunotherapeutics Inc Cetp zur erhöhung des hdl-cholesterol-gehalts
EP0914427B1 (de) 1996-05-01 2006-03-29 Avant Immunotherapeutics, Inc. Impfstoff auf einem plasmid beruhend zur behandlung von atherosclerosis
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US5994310A (en) 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII

Also Published As

Publication number Publication date
DE69626642T2 (de) 2004-01-29
EP0831881A1 (de) 1998-04-01
US7074407B1 (en) 2006-07-11
ATE234109T1 (de) 2003-03-15
WO1996039168A1 (en) 1996-12-12
DE69626642D1 (de) 2003-04-17
JPH11507910A (ja) 1999-07-13
JP3910635B2 (ja) 2007-04-25
CA2223177A1 (en) 1996-12-12
AU6091296A (en) 1996-12-24
AU715410B2 (en) 2000-02-03
EP0831881B1 (de) 2003-03-12
ES2190470T3 (es) 2003-08-01

Similar Documents

Publication Publication Date Title
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
ES2120073T3 (es) Agente inductor de tolerancia inmunologica.
DK0752876T3 (da) Monoklonale antistoffer, som binder til tumorafstødningsantigen-precursor MAGE-1, rekombinant MAGE-1 samt immunogene peptider afledt af MAGE-1
BR9707819A (pt) Imunogenos peptidicos
WO1995029193A3 (en) Melanoma antigens
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
DK0831881T3 (da) CETP til forøgelse af HDL-cholesterolniveau
ATE261314T1 (de) P53 impfstoff
BR0312808A (pt) Proteìna de fusão igg fc/hiv-gp120/c3d
WO1993015207A3 (en) Hepatitis therapeutics
DE69831951D1 (de) Pseudomonas exotoxin-a-ähnliche chimerische immunogene
WO1999065518A3 (en) Lt and ct in parenteral immunization methods against helicobacter infection
DK0676965T3 (da) Fremgangsmåde til at reducere immunogeniciteten af variable regioner på antistoffer
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
GB9818133D0 (en) Vaccine
WO2001034184A3 (en) Methods and compositions for protection against bovine herpesvirus 1
ATE329615T1 (de) Borrelia burgdorferi bacterin
AU6461594A (en) Induction of protection against viral infection
WO2002041921A3 (en) Compositions for protection against bovine viral diseases
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
SE9600436D0 (sv) Vaccine against hantavirus
GR3021983T3 (en) Cross-reactive influenza a immunization
KR970074790A (ko) 합성 펩티드를 함유하는 녹농균 백신 및 이것으로부터 생산된 치료제